Skip to content

Wheeze/asthma exacerbation workflow

Primary care wheeze workflow for rapid severity framing, escalation triggers, and controller-plan reinforcement.

High-risk workflowLast reviewed September 4, 2026

AI-assisted evidence review. Clinical-owner sign-off is not recorded for this update.

Scope

Use for
Outpatient initial management of wheeze/asthma symptoms in patients without immediate respiratory failure signs.
Not for
  • Severe respiratory distress, hypoxia, or exhaustion requiring emergency pathway.
  • Inpatient-level acute asthma management.

Immediate actions

  • Record respiratory rate, pulse, oxygen saturation, speech, work of breathing and air entry; repeat after treatment. Assess prior ICU care, recent steroid courses and reliever response.
  • Consider anaphylaxis, foreign body and other causes of wheeze. Infant bronchiolitis needs a separate age-specific pathway.

Red flags: escalate now

If any of these are present, stop routine steps and follow the urgency stated. Activate emergency care for instability or findings that need immediate transfer.

  • Call emergency services for silent chest, exhaustion, impaired consciousness, cyanosis or marked distress; begin stabilization while transfer is arranged.
  • Persistent hypoxemia or poor bronchodilator response requires emergency assessment. In children, SpO2 below 92% needs urgent oxygen and acute-care management; a reassuring saturation alone does not establish mild disease.

First-line plan

  • Give inhaled rapid bronchodilator treatment using the age-specific acute asthma protocol; MDI with spacer is preferred when feasible. Do not substitute routine as-needed dosing for an exacerbation protocol.
  • Moderate or severe attacks need early systemic corticosteroid assessment and monitored care; do not delay transfer for office investigations.
  • Review technique and adherence. Before discharge, prescribe or optimize an inhaled corticosteroid-containing plan appropriate to age and prior treatment; daily low-dose ICS plus as-needed SABA is the CTS first-line approach to mild asthma. Other regimens require age-specific selection.

Follow-up and monitoring

  • Discharge only after sustained clinical improvement with a feasible reliever schedule and reliable access to care.
  • Provide a written action plan, arrange early reassessment for residual symptoms and complete a control review within 4 weeks in children. Children needing reliever more often than every 4 hours after discharge require reassessment.
  • Review persistent symptoms or more than 2 reliever doses per week for inadequate control.

Linked resources

Before the patient leaves

Return precautions you can say as written:

“If symptoms get worse, new warning signs appear, or you cannot follow the plan from this visit, seek urgent care now.”

About this workflow

Clinical owner
Family Medicine Editorial Team
Risk tier
High
Review cadence
Every 3 months
Last reviewed
September 4, 2026AI-assisted evidence review. Clinical-owner sign-off is not recorded for this update.
Review status
Evidence current. Next review due December 4, 2026.

References